Cephalothin sodium
USP/1102000 - United States Pharmacopeia (USP) Reference Standard
Synonym: Cephalothin sodium salt; 7-
CAS Number: 58-71-9
Empirical Formula (Hill Notation): C16H15N2NaO6S2
Molecular Weight: 418.42
MDL Number: MFCD00072025
Linear Formula: C16H15N2NaO6S2
Product Type: Chemical
API family | cephalothin |
application(s) | pharmaceutical (small molecule) |
format | neat |
grade | pharmaceutical primary standard |
InChI | 1S/C16H16N2O6S2.Na/c1-8(1 |
InChI key | VUFGUVLLDPOSBC-XRZFDKQNSA |
manufacturer/tradename | USP |
SMILES string | [Na+].CC(=O)OCC1=C(N2[C@H |
storage temp. | 2-8°C |
Analysis Note: | These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. |
Application: | Cephalothin sodium USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. |
Biochem/physiol Actions: | Mode of Action: Disrupts the synthesis of the peptidoglycan layer of bacterial cell walls. Antimicrobial spectrum: Effective aginast both Gram-positive and Gram-negative bacteria. Mode of Resistance: Production of cephalosporinase will inactivate the product. |
General description: | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia . |
Other Notes: | Sales restrictions may apply. |
Symbol | GHS08 |
Signal word | Danger |
Hazard statements | H317 - H334 |
Precautionary statements | P261 - P280 - P284 - P304 + P340 - P342 + P311 |
RIDADR | NONH for all modes of transport |
WGK Germany | WGK 2 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
Storage Temp. | 2-8°C |
UNSPSC | 41116107 |